Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Gastric Cancer AI-driven Data Integration Genomic Analysis Biomarker.
- Who it may be relevant to
- Registry conditions: The Study Focuses on Gastric Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Fourth Hospital of Hebei Medical University
Overview
This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.
Interventions
- Diagnostic test Gastric Cancer AI-driven Data Integration Genomic Analysis Biomarker
Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis
Primary outcome measures
- 5-year overall survival [Time frame: 2025-12-31]
Secondary outcome measures (1)
- 5-year recurrence-free survival [Time frame: 2025-12-31]
Eligibility criteria
Inclusion criteria
All patients with gastric cancer
Exclusion criteria
None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Department of General Surgery — Shijiazhuang
Identifiers
NCT: NCT06506825 · HBGCCN